Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 3/2019

24.01.2019 | Editorial

Infective endocarditis caused by Streptococcus agalactiae: time for beta-hemolytic streptococci to follow treatment recommendations for S. aureus?

verfasst von: Parham Sendi

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Excerpt

Infective endocarditis (IE) caused by Streptococcus agalactiae (group B Streptococcus, GBS) is a serious disease. Ivanova-Georgieva et al. [1] recently demonstrated the similarities and differences in the clinical characteristics of left-sided IE caused by GBS and S. aureus. Their results underscored the severity of GBS IE, confirming findings of prior studies [2, 3]. …
Literatur
1.
Zurück zum Zitat Ivanova-Georgieva R, Ruiz-Morales J, Garcia-Cabrera E, Garcia-Lopez MV, Galvez-Acebal J, Plata-Ciezar A, de la Torre Lima J, Hidalgo-Tenorio C, Martinez-Marcos FJ, Garcia DV, Luque R, de Alarcon Gonzalez A (2018) Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious. Eur J Clin Microbiol Infect Dis in this issue Ivanova-Georgieva R, Ruiz-Morales J, Garcia-Cabrera E, Garcia-Lopez MV, Galvez-Acebal J, Plata-Ciezar A, de la Torre Lima J, Hidalgo-Tenorio C, Martinez-Marcos FJ, Garcia DV, Luque R, de Alarcon Gonzalez A (2018) Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious. Eur J Clin Microbiol Infect Dis in this issue
2.
Zurück zum Zitat Ivanova Georgieva R, Garcia Lopez MV, Ruiz-Morales J, Martinez-Marcos FJ, Lomas JM, Plata A, Noureddine M, Hidalgo-Tenorio C, Reguera JM, De la Torre Lima J, Galvez Aceval J, Marquez M, de Alarcon A, Andalusian Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases S (2010) Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohort. J Inf Secur 61(1):54–59 Ivanova Georgieva R, Garcia Lopez MV, Ruiz-Morales J, Martinez-Marcos FJ, Lomas JM, Plata A, Noureddine M, Hidalgo-Tenorio C, Reguera JM, De la Torre Lima J, Galvez Aceval J, Marquez M, de Alarcon A, Andalusian Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases S (2010) Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohort. J Inf Secur 61(1):54–59
3.
Zurück zum Zitat Sambola A, Miro JM, Tornos MP, Almirante B, Moreno-Torrico A, Gurgui M, Martinez E, Del Rio A, Azqueta M, Marco F, Gatell JM (2002) Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature, 1962-1998. Clin Infect Dis 34(12):1576–1584CrossRef Sambola A, Miro JM, Tornos MP, Almirante B, Moreno-Torrico A, Gurgui M, Martinez E, Del Rio A, Azqueta M, Marco F, Gatell JM (2002) Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature, 1962-1998. Clin Infect Dis 34(12):1576–1584CrossRef
4.
Zurück zum Zitat Blackberg A, Nilson B, Ozenci V, Olaison L, Rasmussen M (2018) Infective endocarditis due to Streptococcus dysgalactiae: clinical presentation and microbiological features. Eur J Clin Microbiol Infect Dis 37(12):2261–2272CrossRef Blackberg A, Nilson B, Ozenci V, Olaison L, Rasmussen M (2018) Infective endocarditis due to Streptococcus dysgalactiae: clinical presentation and microbiological features. Eur J Clin Microbiol Infect Dis 37(12):2261–2272CrossRef
5.
Zurück zum Zitat El Rafei A, DeSimone DC, DeSimone CV, Lahr BD, Steckelberg JM, Sohail MR, Wilson WR, Baddour LM (2016) Beta-haemolytic streptococcal endocarditis: clinical presentation, management and outcomes. Infect Dis (Lond) 48(5):373–378CrossRef El Rafei A, DeSimone DC, DeSimone CV, Lahr BD, Steckelberg JM, Sohail MR, Wilson WR, Baddour LM (2016) Beta-haemolytic streptococcal endocarditis: clinical presentation, management and outcomes. Infect Dis (Lond) 48(5):373–378CrossRef
6.
Zurück zum Zitat Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, Document R, Erol C, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM (2015) 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36(44):3075–3128CrossRef Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, Document R, Erol C, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM (2015) 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36(44):3075–3128CrossRef
7.
Zurück zum Zitat Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O'Gara P, Taubert KA, American Heart Association Committee on Rheumatic Fever E, Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435–1486CrossRef Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O'Gara P, Taubert KA, American Heart Association Committee on Rheumatic Fever E, Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435–1486CrossRef
8.
Zurück zum Zitat Lefort A, Lortholary O, Casassus P, Selton-Suty C, Guillevin L, Mainardi JL, beta-Hemolytic Streptococci Infective Endocarditis Study G (2002) Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France. Arch Intern Med 162(21):2450–2456CrossRef Lefort A, Lortholary O, Casassus P, Selton-Suty C, Guillevin L, Mainardi JL, beta-Hemolytic Streptococci Infective Endocarditis Study G (2002) Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France. Arch Intern Med 162(21):2450–2456CrossRef
9.
Zurück zum Zitat Baddour LM (1998) Infective endocarditis caused by beta-hemolytic streptococci. The Infectious Diseases Society of America’s Emerging Infections Network. Clin Infect Dis 26(1):66–71CrossRef Baddour LM (1998) Infective endocarditis caused by beta-hemolytic streptococci. The Infectious Diseases Society of America’s Emerging Infections Network. Clin Infect Dis 26(1):66–71CrossRef
10.
Zurück zum Zitat Smyth EG, Pallett AP, Davidson RN (1988) Group G streptococcal endocarditis: two case reports, a review of the literature and recommendations for treatment. J Inf Secur 16(2):169–176 Smyth EG, Pallett AP, Davidson RN (1988) Group G streptococcal endocarditis: two case reports, a review of the literature and recommendations for treatment. J Inf Secur 16(2):169–176
11.
Zurück zum Zitat Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA, Committee on Rheumatic Fever E, Kawasaki D, Council on Cardiovascular Disease in the Y, Councils on Clinical Cardiology S, Cardiovascular S, Anesthesia, American Heart A, Infectious Diseases Society of A (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111(23):e394–e434PubMed Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA, Committee on Rheumatic Fever E, Kawasaki D, Council on Cardiovascular Disease in the Y, Councils on Clinical Cardiology S, Cardiovascular S, Anesthesia, American Heart A, Infectious Diseases Society of A (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111(23):e394–e434PubMed
12.
Zurück zum Zitat Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A (2000) Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342(1):15–20CrossRef Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A (2000) Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342(1):15–20CrossRef
13.
Zurück zum Zitat Schauf V, Deveikis A, Riff L, Serota A (1976) Antibiotic-killing kinetics of group B streptococci. J Pediatr 89(2):194–198CrossRef Schauf V, Deveikis A, Riff L, Serota A (1976) Antibiotic-killing kinetics of group B streptococci. J Pediatr 89(2):194–198CrossRef
14.
Zurück zum Zitat Overturf GD, Horowitz M, Wilkins J, Leedom J, Steinberg E (1977) Bactericidal studies of penicillin-gentamicin combinations against group B streptococci. J Antibiot (Tokyo) 30(6):513–518CrossRef Overturf GD, Horowitz M, Wilkins J, Leedom J, Steinberg E (1977) Bactericidal studies of penicillin-gentamicin combinations against group B streptococci. J Antibiot (Tokyo) 30(6):513–518CrossRef
15.
Zurück zum Zitat Deveikis A, Schauf V, Mizen M, Riff L (1977) Antimicrobial therapy of experimental group B streptococcal infection in mice. Antimicrob Agents Chemother 11(5):817–820CrossRef Deveikis A, Schauf V, Mizen M, Riff L (1977) Antimicrobial therapy of experimental group B streptococcal infection in mice. Antimicrob Agents Chemother 11(5):817–820CrossRef
16.
Zurück zum Zitat Cooper MD, Keeney RE, Lyons SF, Cheatle EL (1979) Synergistic effects of ampicillin-aminoglycoside combinations on group B streptococci. Antimicrob Agents Chemother 15(3):484–486CrossRef Cooper MD, Keeney RE, Lyons SF, Cheatle EL (1979) Synergistic effects of ampicillin-aminoglycoside combinations on group B streptococci. Antimicrob Agents Chemother 15(3):484–486CrossRef
17.
Zurück zum Zitat Kim KS, Anthony BF (1981) Penicillin tolerance in group B streptococci isolated from infected neonates. J Infect Dis 144(5):411–419CrossRef Kim KS, Anthony BF (1981) Penicillin tolerance in group B streptococci isolated from infected neonates. J Infect Dis 144(5):411–419CrossRef
18.
Zurück zum Zitat Baker CN, Thornsberry C, Facklam RR (1981) Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother 19(5):716–725CrossRef Baker CN, Thornsberry C, Facklam RR (1981) Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother 19(5):716–725CrossRef
19.
Zurück zum Zitat Needham JR, Altman DG, Whitelaw AG (1982) Ampicillin and penicillin compared for the treatment of experimental group B streptococcal septicaemia in mice. Med Lab Sci 39(3):271–274PubMed Needham JR, Altman DG, Whitelaw AG (1982) Ampicillin and penicillin compared for the treatment of experimental group B streptococcal septicaemia in mice. Med Lab Sci 39(3):271–274PubMed
20.
Zurück zum Zitat Swingle HM, Bucciarelli RL, Ayoub EM (1985) Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci. J Infect Dis 152(3):515–520CrossRef Swingle HM, Bucciarelli RL, Ayoub EM (1985) Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci. J Infect Dis 152(3):515–520CrossRef
21.
Zurück zum Zitat Kim KS (1987) Effect of antimicrobial therapy for experimental infections due to group B Streptococcus on mortality and clearance of bacteria. J Infect Dis 155(6):1233–1241CrossRef Kim KS (1987) Effect of antimicrobial therapy for experimental infections due to group B Streptococcus on mortality and clearance of bacteria. J Infect Dis 155(6):1233–1241CrossRef
22.
Zurück zum Zitat Rello J, van Engelen TSR, Alp E, Calandra T, Cattoir V, Kern WV, Netea MG, Nseir S, Opal SM, van de Veerdonk FL, Wilcox MH, Wiersinga WJ (2018) Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect 24(12):1264–1272CrossRef Rello J, van Engelen TSR, Alp E, Calandra T, Cattoir V, Kern WV, Netea MG, Nseir S, Opal SM, van de Veerdonk FL, Wilcox MH, Wiersinga WJ (2018) Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect 24(12):1264–1272CrossRef
23.
Zurück zum Zitat Ruppen C, Lupo A, Decosterd L, Sendi P (2016) Is penicillin plus gentamicin synergistic against clinical group B Streptococcus isolates?: an in vitro study. Front Microbiol 7:1680CrossRef Ruppen C, Lupo A, Decosterd L, Sendi P (2016) Is penicillin plus gentamicin synergistic against clinical group B Streptococcus isolates?: an in vitro study. Front Microbiol 7:1680CrossRef
24.
Zurück zum Zitat Ruppen C, Decosterd L, Sendi P (2017) Is gentamicin necessary in the antimicrobial treatment for group B streptococcal infections in the elderly? An in vitro study with human blood products. Infect Dis (Lond) 49(3):185–192CrossRef Ruppen C, Decosterd L, Sendi P (2017) Is gentamicin necessary in the antimicrobial treatment for group B streptococcal infections in the elderly? An in vitro study with human blood products. Infect Dis (Lond) 49(3):185–192CrossRef
26.
Zurück zum Zitat Sendi P, Ericsson M, Olaison L (2012) Infective endocarditis caused by group B Streptococcus: the role of aminoglycoside-combination. J Inf Secur 64(1):127–129 Sendi P, Ericsson M, Olaison L (2012) Infective endocarditis caused by group B Streptococcus: the role of aminoglycoside-combination. J Inf Secur 64(1):127–129
27.
Zurück zum Zitat Bayer AS, Murray BE (2009) Initial low-dose aminoglycosides in Staphylococcus aureus bacteremia: good science, urban legend, or just plain toxic? Clin Infect Dis 48(6):722–724CrossRef Bayer AS, Murray BE (2009) Initial low-dose aminoglycosides in Staphylococcus aureus bacteremia: good science, urban legend, or just plain toxic? Clin Infect Dis 48(6):722–724CrossRef
28.
Zurück zum Zitat Le T, Bayer AS (2003) Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 36(5):615–621CrossRef Le T, Bayer AS (2003) Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 36(5):615–621CrossRef
29.
Zurück zum Zitat Korzeniowski O, Sande MA (1982) Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med 97(4):496–503CrossRef Korzeniowski O, Sande MA (1982) Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med 97(4):496–503CrossRef
30.
Zurück zum Zitat Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fatkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, Sa E, Bacteremia Study G (2006) Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355(7):653–665CrossRef Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fatkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, Sa E, Bacteremia Study G (2006) Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355(7):653–665CrossRef
31.
Zurück zum Zitat Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW (2009) Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 48(6):713–721CrossRef Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW (2009) Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 48(6):713–721CrossRef
Metadaten
Titel
Infective endocarditis caused by Streptococcus agalactiae: time for beta-hemolytic streptococci to follow treatment recommendations for S. aureus?
verfasst von
Parham Sendi
Publikationsdatum
24.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 3/2019
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-03446-2

Weitere Artikel der Ausgabe 3/2019

European Journal of Clinical Microbiology & Infectious Diseases 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.